Home›People›Richard Peters
Richard Peters

Richard Peters

Director at Aprea Therapeutics. Also a founder & executive chairman at TellBio.

ExecutiveDirectorPublic company
Updated Nov 10, 2026·Latest SEC filing Jun 17, 2026·Suggest an edit

About Richard Peters

Richard Peters is a director at Aprea Therapeutics.

Form D filings name Richard Peters as a founder & executive chairman at TellBio.

Richard Peters reports to the SEC as a director or officer of 3 public companies, including Kineta (KANT) and Merrimack Pharmaceuticals (MACK).

Richard Peters first appears on SEC filings in 2017.

Experience

This experience comes from Richard Peters's profile and from SEC filings. For roles taken from filings, the years are when the filings name Richard Peters in the role, so the role may have started earlier or lasted longer.

Pharming Group N.V. Current
Chairman of the Board of Directors (EURONEXT:PHARM; NASDAQ:PHAR)
2023 – Present
Aprea Therapeutics, Inc. Current
Chairman of the Board and Chair of the Compensation Committee (NASDAQ:APRE)
2020 – Present · Public company (APRE)
TellBio, Inc. Current
Founder and Executive Chairman
2019 – Present · Andover, MA
Develops a system that isolates tumor cells from blood samples for cancer researchers.
Aura Biosciences Current
Investor and Corporate Advisor (NASDAQ:AURA)
2014 – Present
Kineta, Inc.
President and CEO, director
Lead Independent Director & Chair of Nomination & Governance Committee (NASDAQ:KA) (2022 – 2025)
2020 – 2025 · Public company (KANT)
Yumanity Therapeutics
President, CEO, and Director (NASDAQ:YMTX)
2019 – 2022
Merrimack Pharmaceuticals Inc.
President and CEO, director
Corporate Advisor (2017 – 2021)
2017 – 2021 · Public company (MACK)
Sanofi Genzyme (NASDAQ:SNY)
SVP, Head of Global Rare Diseases and JAPAC Specialty Care BU Head (2015 – 2017)
Division Medical Officer (NASDAQ:SNY) (2011 – 2014)
2011 – 2017
X4 Pharmaceuticals
Co-Founder, Investor, and Director (NASDAQ:XFOR)
2014 – 2015
Genzyme (NASDAQ:SNY)
Strategy Development Officer (2014)
Vice President, Global and US Medical Affairs (2008 – 2011)
2008 – 2014
Onyx Pharmaceuticals (NASDAQ:ONXX)
Sr. Director, Medical Affairs
2006 – 2008
Amgen
Director Medical Affairs (NASDAQ:AMGN)
2003 – 2006
Mednav (Private)
CEO
1997 – 2003
Massachusetts General Hospital
Instructor in Medicine
1993 – 1997

Key Colleagues at Startups

The people Richard Peters works with at each company, as listed on that company's latest Form D.

TellBio, Inc. · Form D/A, Mar 24, 2026
Gary Crocker
Gary Crocker
Director, TellBio
Bernard Peters
Bernard Peters
Director, TellBio

Sources

  1. SECTellBio, Inc. Form D/A, filed Mar 24, 2026
  2. SECForms 3, 4 and 5 filed by Richard Peters (SEC filer 1697628)